{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:51:54Z","timestamp":1794718314414,"version":"4.9.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.aohep.2021.100653","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T22:50:27Z","timestamp":1639781427000},"page":"100653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Management of COVID-19 patients with chronic liver diseases and liver transplants"],"prefix":"10.1016","volume":"27","author":[{"given":"Xinyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2021.100653_bib0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0002","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jmv.26424","article-title":"Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes","volume":"93","author":"Li","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.aohep.2021.100653_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.14218\/JCTH.2020.00019","article-title":"Characteristics and mechanism of liver injury in 2019 coronavirus disease","volume":"8","author":"Li","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0004","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12072-020-10078-2","article-title":"Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis","volume":"14","author":"Kovalic","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12072-020-10058-6","article-title":"Effect of COVID-19 on patients with compensated chronic liver diseases","volume":"14","author":"Ji","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0006","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.cgh.2020.06.011","article-title":"Clinical features and outcomes of coronavirus disease 2019 (COVID-19) patients with chronic Hepatitis B virus infection","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0007","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/jmv.26740","article-title":"Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses","volume":"93","author":"Sarkar","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.aohep.2021.100653_bib0008","article-title":"Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study","author":"Liu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0009","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jmv.26201","article-title":"A case series of COVID-19 patients with chronic hepatitis B virus infection","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.aohep.2021.100653_bib0010","first-page":"e10923","article-title":"COVID-19-induced hepatic injury: a systematic review and meta-analysis","volume":"12","author":"Abdulla","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.aohep.2021.100653_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jvh.13410","article-title":"Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy","volume":"28","author":"Rodriguez-Tajes","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2021.100653_bib0012","doi-asserted-by":"crossref","unstructured":"Cerbu B., Pantea S., Bratosin F., Vidican I., Turaiche M., Frent S., et\u00a0al. Liver impairment and hematological changes in patients with chronic Hepatitis C and COVID-19: a retrospective study after one year of pandemic. 2021:57. doi: 10.3390\/medicina57060597.","DOI":"10.3390\/medicina57060597"},{"key":"10.1016\/j.aohep.2021.100653_bib0013","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.12998\/wjcc.v8.i22.5831","article-title":"Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?","volume":"8","author":"Mangia","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.aohep.2021.100653_bib0014","article-title":"A case of severe acute respiratory syndrome coronavirus 2 treatment with remdesivir in a Hepatitis C-coinfected patient resulting in temporary viral control and posttreatment flare","volume":"8","author":"da Cunha","year":"2021"},{"key":"10.1016\/j.aohep.2021.100653_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCG.0000000000001459","article-title":"WGO guidance for the care of patients with COVID-19 and liver disease","volume":"55","author":"Hamid","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100653_bib0016","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International Consensus P. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100653_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1592","article-title":"Clinical features of COVID-19 patients with non-alcoholic fatty liver disease","author":"Huang","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2021.100653_bib0018","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.dsx.2020.06.013","article-title":"Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19","volume":"14","author":"Sharma","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.aohep.2021.100653_bib0019","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biochi.2020.08.018","article-title":"Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?","volume":"179","author":"Ferron","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.aohep.2021.100653_bib0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17474124.2020.1801417","article-title":"MAFLD in COVID-19 patients: an insidious enemy","volume":"14","author":"Dongiovanni","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0021","doi-asserted-by":"crossref","unstructured":"Pan L., Huang P., Xie X., Xu J., Guo D., Jiang Y. Metabolic associated fatty liver disease increases the severity of COVID-19: a meta-analysis. Dig Liver Dis2020. doi: 10.1016\/j.dld.2020.09.007.","DOI":"10.1016\/j.dld.2020.09.007"},{"key":"10.1016\/j.aohep.2021.100653_bib0022","first-page":"1","article-title":"NAFLD and COVID-19: a pooled analysis","author":"Sachdeva","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.aohep.2021.100653_bib0023","doi-asserted-by":"crossref","first-page":"e13338","DOI":"10.1111\/eci.13338","article-title":"COVID-19 and non-alcoholic fatty liver disease: two intersecting pandemics","volume":"50","author":"Portincasa","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.aohep.2021.100653_bib0024","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100653_bib0025","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/liv.14575","article-title":"Metabolic-associated fatty liver disease is associated with severity of COVID-19","volume":"40","author":"Zhou","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0026","doi-asserted-by":"crossref","unstructured":"Lefere S., T.a.c.k.e. FJJriih. Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism. 2019:1:30-43. doi: 10.1016\/j.jhepr.2019.02.004.","DOI":"10.1016\/j.jhepr.2019.02.004"},{"key":"10.1016\/j.aohep.2021.100653_bib0027","article-title":"REGEN-COV antibody combination and outcomes in outpatients with Covid-19","author":"Weinreich","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2021.100653_bib0028","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/cld.974","article-title":"Chronic liver disease and COVID-19: alcohol use disorder\/alcohol-associated liver disease, nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis, autoimmune liver disease, and compensated cirrhosis","volume":"15","author":"Kushner","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.aohep.2021.100653_bib0029","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.31797","article-title":"Outcome of COVID-19 in patients with autoimmune hepatitis: an international multicenter study","volume":"73","author":"Efe","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100653_bib0030","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-CoV-2 infection in patients with autoimmune hepatitis","volume":"74","author":"Marjot","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/jim-2021-001871","article-title":"Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic","author":"Vuppalanchi","year":"2021","journal-title":"J Investig Med"},{"key":"10.1016\/j.aohep.2021.100653_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1557","article-title":"Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients","author":"Gerussi","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2021.100653_bib0033","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-020-10054-w","article-title":"Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations","volume":"14","author":"Lau","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0034","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0035","first-page":"115:1544","article-title":"ACE2: a linkage for the interplay between COVID-19 and decompensated cirrhosis","author":"Gao","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100653_bib0036","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","article-title":"Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)","volume":"14","author":"Sarin","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-321666","article-title":"Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study","author":"Qi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100653_bib0038","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.jinf.2020.06.029","article-title":"Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes","volume":"81","author":"Liu","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.aohep.2021.100653_bib0039","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12072-020-10051-z","article-title":"Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China","volume":"14","author":"Qi","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0040","article-title":"Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort","author":"Bajaj","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100653_bib0041","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12664-020-01074-3","article-title":"Poor outcomes in patients with cirrhosis and Corona Virus Disease-19","volume":"39","author":"Shalimar","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100653_bib0042","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0043","doi-asserted-by":"crossref","unstructured":"Desai A., Sachdeva S., Parekh T., Desai R.J. Jgo. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. 2020:6:557-559. doi: 10.1200\/go.20.00097.","DOI":"10.1200\/GO.20.00097"},{"key":"10.1016\/j.aohep.2021.100653_bib0044","doi-asserted-by":"crossref","unstructured":"Kim D., Adeniji N., Latt N., Kumar S., Bloom P., Aby E., et\u00a0al. Predictors of outcomes of COVID-19 in patients with chronic liver disease: US Multi-center Study. 2021:19:1469-1479.e19. doi: 10.1016\/j.cgh.2020.09.027.","DOI":"10.1016\/j.cgh.2020.09.027"},{"key":"10.1016\/j.aohep.2021.100653_bib0045","article-title":"Guidelines adaptation to the COVID-19 outbreak for the management of hepatocellular carcinoma","author":"Santambrogio","year":"2020","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"10.1016\/j.aohep.2021.100653_bib0046","doi-asserted-by":"crossref","first-page":"e2192","DOI":"10.6061\/clinics\/2020\/e2192","article-title":"Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement","volume":"75","author":"Chagas","year":"2020","journal-title":"Clinics"},{"key":"10.1016\/j.aohep.2021.100653_bib0047","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000510765","article-title":"Impacts of COVID-19 on liver cancers: during and after the pandemic","volume":"9","author":"Chan Stephen","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.aohep.2021.100653_bib0048","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0049","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-020-10103-4","article-title":"APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19","author":"Shiina","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0050","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014985","article-title":"Why is organ transplantation clinically important?","volume":"3","author":"Grinyo","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.aohep.2021.100653_bib0051","doi-asserted-by":"crossref","first-page":"e13335","DOI":"10.1111\/tid.13335","article-title":"COVID-19 and liver transplantation: Lessons learned from three reported cases","volume":"22","author":"Gao","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.aohep.2021.100653_bib0052","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.3748\/wjg.v26.i44.7076","article-title":"COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report","volume":"26","author":"Sessa","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100653_bib0053","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/gutjnl-2020-321923","article-title":"COVID-19 in an international European liver transplant recipient cohort","volume":"69","author":"Becchetti","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100653_bib0054","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.transproceed.2020.07.012","article-title":"Clinical presentation, treatment, and mortality rate in liver transplant recipients with coronavirus disease 2019: a systematic review and quantitative analysis","volume":"52","author":"Fraser","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.aohep.2021.100653_bib0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12072-020-10043-z","article-title":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation","volume":"14","author":"Liu","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0056","article-title":"Prognosis and treatment of liver transplant recipients in the COVID-19 era: a literature review","volume":"25","author":"Imam","year":"2020","journal-title":"Ann Transplant"},{"key":"10.1016\/j.aohep.2021.100653_bib0057","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"Colmenero","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0058","doi-asserted-by":"crossref","first-page":"713","DOI":"10.34172\/aim.2020.92","article-title":"Management of patients with liver transplant and chronic liver diseases during COVID-19 pandemic: a brief review","volume":"23","author":"Taher","year":"2020","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.aohep.2021.100653_bib0059","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/lt.25756","article-title":"Coronaviruses and immunosuppressed patients: the facts during the third epidemic","volume":"26","author":"D'Antiga","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.aohep.2021.100653_bib0060","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/hep.31257","article-title":"Perioperative presentation of COVID-19 disease in a liver transplant recipient","volume":"72","author":"Qin","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100653_bib0061","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/ajt.16548","article-title":"Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor","volume":"21","author":"Manzia","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.aohep.2021.100653_bib0062","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12072-020-10041-1","article-title":"Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI)","volume":"14","author":"Saigal","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2021.100653_bib0063","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hep.31281","article-title":"Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement","volume":"72","author":"Fix","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100653_bib0064","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.001","article-title":"AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19","volume":"159","author":"Sultan","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100653_bib0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0066","article-title":"SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients","author":"Ruether","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100653_bib0067","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.dld.2021.03.013","article-title":"Italian association for the study of the liver position statement on SARS-CoV2 vaccination","volume":"53","author":"Russo","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aohep.2021.100653_bib0068","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients","volume":"74","author":"Cornberg","year":"2021","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121003550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121003550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:43:40Z","timestamp":1761648220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268121003550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1665268121003550"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100653","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of COVID-19 patients with chronic liver diseases and liver transplants","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100653"}}